An Observational Study on Treatment Compliance by Children Treated With Growth Hormone (IMPACT)

Novo Nordisk

Status: Withdrawn

Conditions: Growth Hormone Deficiency in Children; Growth Hormone Disorder

Treatments: Behavioral: No treatment given

Study type: Observational

Funder types: Industry

Identifiers

NCT01068639

U1111-1113-2490 (Other Identifier)

GH-3787

Details and patient eligibility

About

This study is conducted in Europe. This observational study aims at evaluating compliance with growth hormone treatment in children and identifying factors influencing compliance.

Sex: All

Ages: Under 18 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Child treated for at least one year with growth hormone any growth hormone product
• Followed by the participating paediatrician for at least 1 year.

Exclusion criteria

• Refusal to participate
• Child and/or parent unable to give consent or fill out the questionnaires
• Child participating in a therapeutic trial

Trial design

0 participants in 1 patient group

A

Treatment:

Behavioral: No treatment given